Navigation Links
Blocking crucial molecule could help treat multiple sclerosis, Jefferson neuroscientists say
Date:4/24/2011

PHILADELPHIAReporting in Nature Immunology, Jefferson neuroscientists have identified a driving force behind autoimmune diseases such as multiple sclerosis (MS), and suggest that blocking this cell-signaling molecule is the first step in developing new treatments to eradicate these diseases.

Researchers led by Abdolmohamad Rostami, M.D., Ph.D., Professor and Chairman of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University, found that GM-CSF, which stands for Granulocyte-macrophage colony-stimulating factor, appears to be the key culprit in the onset of MS, because without it, T helper 17 cells (Th17) cells did not induce the MS-like disease in an experimental animal model.

Th17 cells have been shown to play an important pathogenic role in humans and experimental models of autoimmune diseases, but the mechanisms behind this have remained elusive until now.

"There was no connection between GM-CSF and Th17 cells before," said Dr. Rostami. "What we have shown in this paper is that GM-CSF derived from Th17 cells is important in the cell-signaling process that leads to inflammation in the central nervous system."

"Now we know how the Th17 cells work and a better understanding of this mechanism and biology leads to new therapeutics," he adds.

The results suggest that blocking GM-CSF activity may be a successful therapeutic strategy in MS, one of the most common neurological diseases affecting young adults, and other autoimmune diseases, said Dr. Rostami, who is also the Chair of Neurology at Thomas Jefferson University Hospital.

The paper first appe
'/>"/>

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection
2. Blocking cell movement for cancer, MS treatment
3. Blocking cancer in its path: New cellular defect discovered
4. How blocking the Programmed Death 1 protein may treat or prevent sepsis and severe infection
5. Cranberry juice shows promise blocking Staph infections
6. Tiny RNA molecules control labor, may be key to blocking premature birth
7. Blocking the critical structure that lets cancer cells move -- their feet
8. Blocking rogue gene could stop the spread of most cancers
9. Hidden infections crucial to understanding, controlling disease outbreaks
10. Mayo researchers identify dangerous two-faced protein crucial to breast cancer spread and growth
11. In lung cancer, silencing one crucial gene disrupts normal functioning of genome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blocking crucial molecule could help treat multiple sclerosis, Jefferson neuroscientists say
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... March 10, 2015  NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the ... smart wallet has been named the "Number One ... Rethink Modern ( http://www.rethinkmodern.com/ ) is ... your home and lifestyle that have a unique function ...
(Date:3/2/2015)... Ala. , March 2, 2015  Businesses ... processing. Data protection company Tharon Rankins Enterprises has ... that provides an ultra-safe way for businesses to ... their financial transactions. Beconux is ... Tharon Rankins Enterprises. Functioning similarly to an ATM ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Personal Data Protection Company Launches New Product 2
... the National Institute of Allergy and Infectious Diseases ... have determined how a promising drug candidate attacks ... this week in Proceedings of the National Academy ... the drug candidate, PA-824, which targets Mycobacterium tuberculosis ...
... Cyberkinetics Neurotechnology Systems, Inc., Case Western Reserve University and ... have been awarded a five-year, $4.4 million contract from ... component of the National Institute of Child Health and ... receive up to $2.3 million of the total award ...
... foothold in understanding how p53 protects against cancer, the ... lifespan are not well studied. In work reported this ... new evidence that despite the protective role of p53 ... p53 activity--at least in some cell types--may indeed contribute ...
Cached Biology News:NIAID researchers show how promising TB drug works 2NIAID researchers show how promising TB drug works 3Cyberkinetics, Case to develop system to help restore extremity function 2Cyberkinetics, Case to develop system to help restore extremity function 3Cyberkinetics, Case to develop system to help restore extremity function 4Cyberkinetics, Case to develop system to help restore extremity function 5Cyberkinetics, Case to develop system to help restore extremity function 6New clues to the dark side of a key anti-tumor guardian 2
(Date:3/25/2015)... 2015 Agnition announced today that it ... Farmer, airing for the first time at 7:30 a.m. ... Farmer will explore the extremely important role soil microbes ... a patented Microbial Catalyst™ technology that enhances soil and ... segment will air again on April 28. , A ...
(Date:3/25/2015)... Hills, IL (PRWEB) March 25, 2015 ... Cole-Parmer® Symmetry® Top-Loading Balances and Analytical Balances to ... The expanded line of weighing balances from the ... Precision Toploading Balances increase your efficiency by ... a variety of samples. Weighing modes include parts ...
(Date:3/25/2015)... CA (PRWEB) March 25, 2015 ... for Novel Mechanism of Action in Neuromuscular Diseases ... 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the ... skeletal muscle troponin activator tirasemtiv in the journal ... Phase IIa “Evidence of Effect” or hypothesis-generating clinical ...
(Date:3/25/2015)... , March 25, 2015 /CNW/ - The Gairdner ... the 2015 Canada Gairdner Awards, recognizing some of the ... Among the world,s most esteemed ... in science and provide a $100,000 (CDN) prize to each ... stronger culture of research and innovation across the ...
Breaking Biology Technology:Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 62015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 22015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 32015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 42015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 52015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 62015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 72015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 8
... 2010 Advanced Life Sciences Holdings, Inc. ... company engaged in the discovery, development and commercialization of ... and respiratory diseases, today announced that it has submitted ... and Infectious Diseases (NIAID) under BAA-NIAID-DMID-NIHAI2010097 Development Of ...
... colleague Professor Kostya Novoselov won the 2010 Nobel Prize ... modified it to make fluorographene a one-molecule-thick material ... and is basically a two-dimensional version of Teflon, showing ... The results are this week reported in the ...
... often indicate that a device,s clock needs resetting. ... Georgia Tech, the blinking number on a small LCD ... conventional electronic devices with nanoscale generators that harvest mechanical ... nanowires. In this case, the mechanical energy comes ...
Cached Biology Technology:Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure 2Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure 3Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure 4Graphene gets a Teflon makeover 2Graphene gets a Teflon makeover 3Nanogenerators grow strong enough to power small conventional electronics 2Nanogenerators grow strong enough to power small conventional electronics 3Nanogenerators grow strong enough to power small conventional electronics 4
Plasmid expressing Zeocin resistance gene....
... FRT-PGK-gb2-neo-FRT-loxP template is designed to allow ... respectively. It combines a prokaryotic promoter ... E.coli with a eukaryotic promoter ... mammalian cells. The prokaryotic promoter gb2 ...
... The loxP-PGK-gb2-neo-loxP template is designed to ... eukaryotic cells. The loxP-PGK-gb2-neo-loxP template ... combines a prokaryotic promoter (gb2) for ... with a eukaryotic promoter (PGK) for ...
... is tailored to highly enrich ... of rat spleen cells. Cells ... (or compatible 0.5 Tesla) immunomagnetic ... CD4+ T cell content of ...
Biology Products: